Prenatal exposure to organophosphate pesticides and brain morphology and white matter microstructure in preadolescents.


Journal

Environmental research
ISSN: 1096-0953
Titre abrégé: Environ Res
Pays: Netherlands
ID NLM: 0147621

Informations de publication

Date de publication:
12 2020
Historique:
received: 23 05 2020
revised: 07 08 2020
accepted: 07 08 2020
pubmed: 18 8 2020
medline: 12 1 2021
entrez: 18 8 2020
Statut: ppublish

Résumé

Prenatal exposure to organophosphate (OP) pesticides associate with impaired neurodevelopment in humans and animal models. However, much uncertainty exists about the brain structural alterations underlying these associations. The objective of this study was to determine whether maternal OP pesticide metabolite concentrations in urine repeatedly measured during gestation are associated with brain morphology and white matter microstructure in 518 preadolescents aged 9-12 years. Data came from 518 mother-child pairs participating in the Generation R Study, a population-based birth cohort from Rotterdam, the Netherlands. Maternal urine concentrations were determined for 6 dialkylphosphates (DAPs) including 3 dimethyl (DM) and 3 diethyl (DE) alkyl phosphate metabolites, collected at early, mid, and late pregnancy. At child's age 9-12 years, magnetic resonance imaging was performed to obtain T1-weighted images for brain volumes and surface-based cortical thickness and cortical surface area, and diffusion tensor imaging was used to measure white matter microstructure through fractional anisotropy (FA) and mean diffusivity (MD). Linear regression models were fit for the averaged prenatal exposure across pregnancy. DM and DE metabolite concentrations were not associated with brain volumes, cortical thickness, and cortical surface area. However, a 10-fold increase in averaged DM metabolite concentrations across pregnancy was associated with lower FA (B = -1.00, 95%CI = -1.80, -0.20) and higher MD (B = 0.13, 95%CI = 0.04, 0.21). Similar associations were observed for DE concentrations. This study provides the first evidence that OP pesticides may alter normal white matter microstructure in children, which could have consequences for normal neurodevelopment. No associations were observed with structural brain morphology, including brain volumes, cortical thickness, and cortical surface area.

Sections du résumé

BACKGROUND
Prenatal exposure to organophosphate (OP) pesticides associate with impaired neurodevelopment in humans and animal models. However, much uncertainty exists about the brain structural alterations underlying these associations. The objective of this study was to determine whether maternal OP pesticide metabolite concentrations in urine repeatedly measured during gestation are associated with brain morphology and white matter microstructure in 518 preadolescents aged 9-12 years.
METHOD
Data came from 518 mother-child pairs participating in the Generation R Study, a population-based birth cohort from Rotterdam, the Netherlands. Maternal urine concentrations were determined for 6 dialkylphosphates (DAPs) including 3 dimethyl (DM) and 3 diethyl (DE) alkyl phosphate metabolites, collected at early, mid, and late pregnancy. At child's age 9-12 years, magnetic resonance imaging was performed to obtain T1-weighted images for brain volumes and surface-based cortical thickness and cortical surface area, and diffusion tensor imaging was used to measure white matter microstructure through fractional anisotropy (FA) and mean diffusivity (MD). Linear regression models were fit for the averaged prenatal exposure across pregnancy.
RESULTS
DM and DE metabolite concentrations were not associated with brain volumes, cortical thickness, and cortical surface area. However, a 10-fold increase in averaged DM metabolite concentrations across pregnancy was associated with lower FA (B = -1.00, 95%CI = -1.80, -0.20) and higher MD (B = 0.13, 95%CI = 0.04, 0.21). Similar associations were observed for DE concentrations.
CONCLUSIONS
This study provides the first evidence that OP pesticides may alter normal white matter microstructure in children, which could have consequences for normal neurodevelopment. No associations were observed with structural brain morphology, including brain volumes, cortical thickness, and cortical surface area.

Identifiants

pubmed: 32805249
pii: S0013-9351(20)30944-0
doi: 10.1016/j.envres.2020.110047
pmc: PMC7657967
mid: NIHMS1622339
pii:
doi:

Substances chimiques

Organophosphates 0
Pesticides 0

Types de publication

Journal Article Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

110047

Subventions

Organisme : NIEHS NIH HHS
ID : HHSN273201500003C
Pays : United States
Organisme : NIEHS NIH HHS
ID : HHSN273201500003O
Pays : United States
Organisme : NIDA NIH HHS
ID : UG3 DA045251
Pays : United States

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Références

Environ Int. 2019 Oct;131:105002
pubmed: 31369979
Neuroimage. 2018 Nov 15;182:207-218
pubmed: 29305910
Environ Health Perspect. 2005 Apr;113(4):494-8
pubmed: 15811842
J Neurosci. 2009 Apr 1;29(13):4263-73
pubmed: 19339620
Ther Drug Monit. 2007 Apr;29(2):150-63
pubmed: 17417068
Environ Health Perspect. 2003 May;111(5):749-56
pubmed: 12727605
Science. 2010 Nov 5;330(6005):779-82
pubmed: 21051629
Toxicology. 2018 Jan 15;393:90-101
pubmed: 29108742
Neuroimage. 2015 Oct 1;119:119-28
pubmed: 26067345
Crit Rev Toxicol. 2008;38 Suppl 2:1-125
pubmed: 18726789
Neurotherapeutics. 2007 Jul;4(3):316-29
pubmed: 17599699
Clin Toxicol (Phila). 2011 Nov;49(9):771-81
pubmed: 22077242
Am J Clin Nutr. 2012 Jun;95(6):1413-21
pubmed: 22572645
Neurotoxicology. 2015 May;48:9-20
pubmed: 25704171
Neuroscience. 2014 Sep 12;276:48-71
pubmed: 24378955
Pharmacol Ther. 2012 Jun;134(3):355-65
pubmed: 22465060
Nat Rev Neurosci. 2018 Feb 16;19(3):123-137
pubmed: 29449712
Environ Sci Pollut Res Int. 2019 Jun;26(18):18267-18290
pubmed: 31041704
Toxicol Appl Pharmacol. 2009 Oct 15;240(2):143-8
pubmed: 19631231
Toxicol Sci. 2006 Aug;92(2):500-6
pubmed: 16675515
Brain Res Bull. 2007 May 30;72(4-6):232-74
pubmed: 17452286
Proc Natl Acad Sci U S A. 2019 Sep 10;116(37):18347-18356
pubmed: 31451641
Dialogues Clin Neurosci. 2013 Sep;15(3):359-84
pubmed: 24174907
Brain Res Dev Brain Res. 2004 Feb 20;148(2):197-206
pubmed: 14766197
Am J Psychiatry. 2018 Jan 1;175(1):54-62
pubmed: 28817944
Environ Health Perspect. 2008 Mar;116(3):340-8
pubmed: 18335101
Brain Res Dev Brain Res. 2005 Mar 22;155(1):71-80
pubmed: 15763277
Epidemiology. 2016 May;27(3):378-88
pubmed: 27035688
Environ Health Perspect. 2003 Dec;111(16):1939-46
pubmed: 14644670
Int J Epidemiol. 2016 Dec 1;45(6):1887-1894
pubmed: 28089956
Environ Res. 2000 Nov;84(3):290-302
pubmed: 11097803
Regul Toxicol Pharmacol. 2003 Jun;37(3):382-95
pubmed: 12758218
Environ Health Perspect. 2003 Nov;111(14):1779-82
pubmed: 14594631
Transl Psychiatry. 2019 Dec 9;9(1):332
pubmed: 31819038
Proc Natl Acad Sci U S A. 2012 May 15;109(20):7871-6
pubmed: 22547821
Eur J Epidemiol. 2016 Dec;31(12):1243-1264
pubmed: 28070760
J Expo Anal Environ Epidemiol. 2004 May;14(3):249-59
pubmed: 15141154
Environ Res. 2004 Nov;96(3):283-9
pubmed: 15364595
J Expo Sci Environ Epidemiol. 2008 Mar;18(2):167-74
pubmed: 17495869
Environ Health Perspect. 2002 May;110(5):549-53
pubmed: 12003762
J Child Psychol Psychiatry. 2016 Jul;57(7):775-93
pubmed: 26987761
NMR Biomed. 2019 Apr;32(4):e3778
pubmed: 28886240
Environ Health Perspect. 2008 Apr;116(4):537-42
pubmed: 18414640
Alzheimers Dement. 2015 Mar;11(3):321-30
pubmed: 25217294
Environ Health Perspect. 2000 Jun;108 Suppl 3:511-33
pubmed: 10852851
Front Psychiatry. 2019 Sep 24;10:696
pubmed: 31607968
Int Arch Occup Environ Health. 2006 Aug;79(7):568-77
pubmed: 16491402
Int J Hyg Environ Health. 2018 Apr;221(3):489-501
pubmed: 29499913
Front Biosci. 2008 Jan 01;13:1240-9
pubmed: 17981626

Auteurs

Michiel A van den Dries (MA)

Erasmus MC, University Medical Center Rotterdam, Department of Child and Adolescent Psychiatry, Rotterdam, 3015 CN, the Netherlands; Erasmus MC, University Medical Center Rotterdam, The Generation R Study Group, Rotterdam, 3015 CN, the Netherlands.

Sander Lamballais (S)

Erasmus MC, University Medical Center Rotterdam, The Generation R Study Group, Rotterdam, 3015 CN, the Netherlands; Erasmus MC, University Medical Center Rotterdam, Department of Epidemiology, Rotterdam, 3015 CN, the Netherlands; Erasmus MC, University Medical Center Rotterdam, Department of Clinical Genetics, Rotterdam, 3015 CN, the Netherlands.

Hanan El Marroun (H)

Erasmus MC, University Medical Center Rotterdam, Department of Child and Adolescent Psychiatry, Rotterdam, 3015 CN, the Netherlands; Erasmus MC, University Medical Center Rotterdam, Department of Pediatrics, Rotterdam, 3015 CN, the Netherlands; Department of Psychology, Education and Child Studies, Erasmus School of Social and Behavioral Sciences, Erasmus University Rotterdam, 3062 PA, the Netherlands.

Anjoeka Pronk (A)

Department of Risk Analysis for Products in Development, TNO, Utrecht, 3584 CB, the Netherlands.

Suzanne Spaan (S)

Department of Risk Analysis for Products in Development, TNO, Utrecht, 3584 CB, the Netherlands.

Kelly K Ferguson (KK)

Epidemiology Branch, National Institute of Environmental Health Sciences, National Institutes of Health, Department of Health and Human Services, Durham, North Carolina, NC, 27709, USA.

Matthew P Longnecker (MP)

Ramboll, Raleigh, North Carolina, NC, 27612, USA.

Henning Tiemeier (H)

Erasmus MC, University Medical Center Rotterdam, Department of Child and Adolescent Psychiatry, Rotterdam, 3015 CN, the Netherlands; Department of Social and Behavioral Sciences, Harvard T. H. Chan School of Public Health, Boston, MA, 02115, USA.

Mònica Guxens (M)

Erasmus MC, University Medical Center Rotterdam, Department of Child and Adolescent Psychiatry, Rotterdam, 3015 CN, the Netherlands; ISGlobal, Barcelona, 08003, Spain; Pompeu Fabra University, Barcelona, 08002, Spain; Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III, 28029, Spain. Electronic address: monica.guxens@isglobal.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH